Next »
AJIC: American Journal of Infection Control
Volume 31, Issue 1
, Pages
1-8
, February 2003
Which antimicrobial impregnated central venous catheter should we use? Modeling the costs and outcomes of antimicrobial catheter use
-
Decision analytic model. (CR-BSI, Catheter-related bloodstream infection.)
Decision analytic model. (CR-BSI, Catheter-related bloodstream infection.)
-
Probability that the minocycline and rifampin catheters are cost-effective (ie, less than $50,000/quality-adjusted life-year threshold or cost-saving) for patients expected to be catheterized for vary
Probability that the minocycline and rifampin catheters are cost-effective (ie, less than $50,000/quality-adjusted life-year threshold or cost-saving) for patients expected to be catheterized for varying lengths of time.(Data were too sparse to estimate the probability of cost-effectiveness for patients catheterized less than 8 days.)
☆ Dr Saint was supported by a Career Development Award from the VA Health Services Research and Development Service during the time much of this work was completed.
☆☆ Reprint requests: David L. Veenstra, PharmD, PhD, Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Box 357630, Seattle, WA 98195.
PII: S0196-6553(02)48235-1
doi: 10.1067/mic.2003.35
© 2003 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
Next »
AJIC: American Journal of Infection Control
Volume 31, Issue 1
, Pages
1-8
, February 2003
